Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 16, 2017
Quantifying Health Utilities in Patients Undergoing Stereotactic Body Radiation Treatment for Liver Metastases for Use in Future Economic EvaluationsB Warren, P Munoz-Schuffenegger, K K W Chan, et al.
Current Oncology (Toronto, Ont.)|March 12, 2019
Conditional approval of cancer drugs in Canada: accountability and impact on public fundingS K Andersen, N Penner, A Chambers, et al.
Current Oncology (Toronto, Ont.)|December 31, 2020
A systematic review and network meta-analysis of second-line therapy in hepatocellular carcinomaS Delos Santos, S Udayakumar, A Nguyen, et al.
Current Oncology (Toronto, Ont.)|April 6, 2013
Cost-effectiveness of systemic therapies for metastatic pancreatic cancerV C Tam, Y J Ko, N Mittmann, et al.
Current Oncology (Toronto, Ont.)|November 11, 2020
Reimbursement recommendations for cancer drugs supported by phase II evidence in CanadaY Y R Li, H Mai, M E Trudeau, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|January 7, 2023
Outcomes Following Treatment with FOLFOX for Patients with Resectable or Potentially Resectable Metastatic Colorectal Cancer: A Population-based Cohort StudyS Habbous, X Tai, T Gill, et al.
Current Oncology (Toronto, Ont.)|June 4, 2020
Nonsurgical management of advanced hepatocellular carcinoma: a clinical practice guidelineB M Meyers, J Knox, R Cosby, et al.
Pageof 3